ID,Title,Released,Class of Spike-Binding Protein,Protein 1,Protein 2,Protein 3,Protein 4,Domain Target on Spike,Notes
7DZY,Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 2490,2021-06-02,Antibody,2490,,,,,
7KLG,SARS-CoV-2 RBD in complex with Fab 15033,2021-02-10,Antibody,15033,,,,RBD,
7L2C,Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD),2021-02-10,Antibody,2-51,,,,NTD,
7LS9,Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein,2021-03-17,Antibody,1-57,,,,,
7L2D,Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein,2021-03-24,Antibody,1-87,,,,NTD,
6XEY,Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4,2020-07-22,Antibody,2-4,,,,,
7LSS,Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7,2021-03-17,Antibody,2-7,,,,,
7L57,Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15,2021-04-14,Antibody,2-15,,,,,
7L5B,Crystallographic structure of neutralizing antibody 2-15 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD).,2021-02-10,Antibody,2-15,,,,RBD,
7LQW,Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike,2021-03-24,Antibody,2-17,,,,NTD,
7LQV,Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike,2021-03-24,Antibody,4-8,,,,NTD,
7L2E,Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein,2021-03-24,Antibody,4-18,,,,NTD,
7RW2,Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein,2021-09-01,Antibody,5-7,,,,NTD,
7L2F,Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein,2021-03-24,Antibody,5-24,,,,NTD,
7N5H,Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein,2021-11-03,Antibody,2-36,,,,,
7L56,Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43,2021-04-14,Antibody,2-43,,,,,
7E3K,Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants,2021-09-15,Antibody,13G9,,,,,
7KLH,SARS-CoV-2 RBD in complex with Fab 15033-7,2021-02-10,Antibody,15033-7,,,,RBD,
7KMK,"cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound",2021-02-10,Antibody,15033-7,,,,RBD,
7KML,"cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound",2021-02-10,Antibody,15033-7,,,,RBD,
7KXJ,"SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-""up"", asymmetric",2021-02-03,Antibody,15033-7,,,,,
7KXK,"SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-""up""-1-""down"" conformation",2021-02-03,Antibody,15033-7,,,,,
7K9Z,Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutralizing antibodies 298 and 52,2020-10-28,Antibody,298,52,,,,
7K9H,"SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)",2021-09-29,Antibody,2B04,,,,,
7K9I,SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2B04 (local refinement),2021-09-29,Antibody,2B04,,,,RBD,
7E5Y,Molecular basis for neutralizing antibody 2B11 targeting SARS-CoV-2 RBD,2021-06-23,Antibody,2B11,,,,RBD,
7L02,Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12,2020-12-30,Antibody,2G12,,,,,
7L06,Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12,2020-12-30,Antibody,2G12,,,,,
7L09,Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound domain-swapped antibody 2G12 from masked 3D refinement,2020-12-30,Antibody,2G12,,,,,
7K9J,SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation),2021-09-29,Antibody,2H04,,,,,
7K9K,SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2H04 (local refinement),2021-09-29,Antibody,2H04,,,,,
7DK4,"S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.",2020-12-02,Antibody,2H2,,,,RBD,
7DK5,"S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab",2020-12-02,Antibody,2H2,,,,RBD,
7DK6,"S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.",2020-12-02,Antibody,2H2,,,,RBD,
7DK7,"S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.",2020-12-02,Antibody,2H2,,,,RBD,
7DCC,"S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab",2020-12-02,Antibody,3C1,,,,RBD,
7DCX,"S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.",2020-12-02,Antibody,3C1,,,,RBD,
7DD2,"S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.",2020-12-02,Antibody,3C1,,,,RBD,
7DD8,"S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab",2020-12-02,Antibody,3C1,,,,RBD,
7KQE,SARS-CoV-2 spike glycoprotein:Fab 3D11 complex,2021-05-26,Antibody,3D11,,,,,
7M7B,SARS-CoV-2 Spike:Fab 3D11 complex focused refinement,2021-05-26,Antibody,3D11,,,,,
7MF1,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1,2021-05-12,Antibody,47D1,,,,RBD,
7AKD,Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment,2021-05-19,Antibody,47D11,,,,,
7C2L,S protein of SARS-CoV-2 in complex bound with 4A8,2020-07-01,Antibody,4A8,,,,NTD,
7E3L,Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants,2021-09-15,Antibody,58G6,,,,,
7M71,SARS-CoV-2 Spike:5A6 Fab complex I focused refinement,2021-05-26,Antibody,5A6,,,,,
7E8C,SARS-CoV-2 S-6P in complex with 9 Fabs,2021-06-09,Antibody,604,N9,368-2,,,
7EAN,immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 6D6,2021-03-31,Antibody,6D6,,,,RBD,
7EAM,immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 7D6,2021-03-17,Antibody,7D6,,,,RBD,
7DZX,Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 8D2,2021-06-02,Antibody,8D2,,,,,
7KS9,Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab,2021-02-10,Antibody,910-30,,,,,
7LRS,Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain,2021-07-14,Antibody,A23-58.1,,,,RBD,
7LRT,Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain,2021-07-14,Antibody,A23-58.1,,,,RBD,
7E3C,SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD),2021-09-01,Antibody,Ab1,,,,RBD,
7MJJ,Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 1),2021-05-12,Antibody,ab1,,,,,
7MJK,Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2),2021-05-12,Antibody,ab1,,,,,
7MJL,Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (focused refinement of RBD and Fab ab1),2021-05-12,Antibody,ab1,,,,,
7E39,SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3),2021-09-01,Antibody,Ab4,,,,,
7E3B,SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),2021-09-01,Antibody,Ab5,,,,RBD,
7L7D,Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895,2021-09-01,Antibody,AZD8895,,,,RBD,
7L7E,Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061,2021-09-01,Antibody,AZD8895,AZD1061,,,RBD,
7MLZ,Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain,2021-07-28,Antibody,B1-182.1,,,,RBD,
7MM0,Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain,2021-07-28,Antibody,B1-182.1,,,,RBD,
7BZ5,Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody,2020-05-13,Antibody,B38,,,,RBD,
7M53,B6 Fab fragment bound to the SARS-CoV/SARS-CoV-2 spike stem helix peptide,2021-05-26,Antibody,B6,,,,,
7CHB,Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab,2020-09-16,Antibody,BD-236,,,,RBD,
7CHE,Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab and BD-368-2 Fab,2020-09-16,Antibody,BD-236,BD-368-2,,,RBD,
7CHH,Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs,2020-09-16,Antibody,BD-368-2,,,,,
7E86,Crystal structure of the SARS-CoV-2 S RBD in complex with BD-508 Fab,2021-06-09,Antibody,BD-508,,,,RBD,
7E88,Crystal structure of the SARS-CoV-2 S RBD in complex with BD-515 Fab,2021-06-09,Antibody,BD-515,,,,RBD,
7CH4,Crystal structure of the SARS-CoV-2 S RBD in complex with BD-604 Fab,2020-09-16,Antibody,BD-604,,,,RBD,
7CHF,Crystal structure of the SARS-CoV-2 RBD in complex with BD-604 Fab and BD-368-2 Fab,2020-09-16,Antibody,BD-604,BD-368-2,,,RBD,
7E7Y,Crystal structure of the SARS-CoV-2 S RBD in complex with BD-623 Fab,2021-06-09,Antibody,BD-623,,,,RBD,
7CH5,Crystal structure of the SARS-CoV-2 S RBD in complex with BD-629 Fab,2020-09-16,Antibody,BD-629,,,,RBD,
7CHC,Crystal structure of the SARS-CoV-2 S RBD in complex with BD-629 Fab and BD-368-2 Fab,2020-09-16,Antibody,BD-629,BD-368-2,,,RBD,
7EY4,Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667,2021-09-08,Antibody,BD-667,,,,,
7EY5,Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-771 Fab and BD-821 Fab,2021-09-08,Antibody,"BD-771
BD-821",,,,,
7EYA,Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab,2021-09-08,Antibody,BD-804,,,,,
7EZV,local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-812 Fab and BD-836 Fab,2021-09-08,Antibody,BD-812,,,,,
7EY0,Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-813 Fab and BD-744 Fab,2021-09-08,Antibody,BD-813,BD-744,,,,
7BYR,BD23-Fab in complex with the S ectodomain trimer,2020-06-10,Antibody,BD23,,,,,
7M6F,"Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22",2021-05-05,Antibody,BG1-22,,,,,
7M6I,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24",2021-05-05,Antibody,BG1-24,,,,,
7M6E,"Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19",2021-05-05,Antibody,BG10-19,,,,,
7M6D,Structure of the SARS-CoV-2 RBD in complex with neutralizing antibodies BG4-25 and CR3022,2021-05-05,Antibody,BG4-25,CR3022,,,RBD,
7M6G,"Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15",2021-05-05,Antibody,BG7-15,,,,,
7M6H,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20",2021-05-05,Antibody,BG7-20,,,,,
7K8S,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",2020-10-21,Antibody,C002,,,,,
7K8T,"Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)",2020-10-21,Antibody,C002,,,,,
7RKU,"Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C022",2021-09-22,Antibody,C022,,,,RBD,
7R8M,Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032,2021-08-04,Antibody,C032,,,,,
7R8N,Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051,2021-08-04,Antibody,C051,,,,,
7N3I,Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098,2021-08-04,Antibody,C098,,,,RBD,
7R8L,Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody C099 and CR3022,2021-08-04,Antibody,C099,CR3022,,,RBD,
7K8M,"Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C102",2020-10-21,Antibody,C102,,,,RBD,
7K8U,"Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104",2020-10-21,Antibody,C104,,,,,
6XCM,Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1),2020-07-01,Antibody,C105,,,,,
6XCN,Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2),2020-07-01,Antibody,C105,,,,,
7K8V,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110",2020-10-21,Antibody,C110,,,,,
7RKV,Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1),2021-09-22,Antibody,C118,,,,,
7K8W,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119",2020-10-21,Antibody,C119,,,,,
7K8X,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)",2020-10-21,Antibody,C121,,,,,
7K8Y,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)",2020-10-21,Antibody,C121,,,,,
7N62,SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction),2021-08-04,Antibody,C12C9,,,,,
7K8Z,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135",2020-10-21,Antibody,C135,,,,,
7K90,"Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144",2020-10-21,Antibody,C144,,,,,
7KFV,Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B12 Fab),2020-12-02,Antibody,C1A-B12,,,,RBD,
7KFW,Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab),2020-12-02,Antibody,C1A-B3,,,,RBD,
7KFX,Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-C2 Fab),2020-12-02,Antibody,C1A-C2,,,,RBD,
7KFY,Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-F10 Fab),2020-12-02,Antibody,C1A-F10,,,,RBD,
7OAN,Nanobody C5 bound to Spike,2021-08-11,Nanobody/Sybody,C5,,,,,
7OAO,Nanobody C5 bound to RBD,2021-08-11,Nanobody/Sybody,C5,,,,RBD,
7OAU,Nanobody C5 bound to Kent variant RBD (N501Y),2021-08-11,Nanobody/Sybody,C5,,,,RBD,Mutant
7R8O,Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548,2021-08-04,Antibody,C548,,,,,
7E23,SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),2021-05-05,Antibody,CA521,,,,RBD,
7C01,Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD,2020-05-27,Antibody,CB6,,,,RBD,
6XC2,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1,2020-07-08,Antibody,CC12.1,,,,RBD,
6XC3,Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022,2020-07-08,Antibody,CC12.1,CR3022,,,RBD,
6XC4,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3,2020-07-08,Antibody,CC12.3,,,,RBD,
6XC7,Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022,2020-07-08,Antibody,CC12.3,CR3022,,,RBD,
7KN6,Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3,2021-01-20,"Antibody
Nanobody",CC12.3,VHH V,,,RBD,
7KN7,Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH W and antibody Fab CC12.3,2021-01-20,"Antibody
Nanobody",CC12.3,VHH W,,,RBD,
7F62,Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-25 (Focused refinement of S-RBD and chAb-25 region),2021-08-04,Antibody,chAb-25,,,,,
7F63,Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-45 (Focused refinement of S-RBD and chAb-45 region),2021-08-04,Antibody,chAb-45,,,,,
7M8J,SARS-CoV-2 S-NTD + Fab CM25,2021-05-19,Antibody,CM25,,,,NTD,
7S4S,Crystal Structure of SARS-CoV-2 S receptor-binding domain (RBD) in complex CoV11 Fab,2021-09-22,Antibody,CoV11,,,,RBD,
7JMW,Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab,2020-10-14,Antibody,COVA1-16,,,,RBD,
7JMO,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04,2020-08-26,Antibody,COVA2-04,,,,RBD,
7JMP,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39,2020-08-26,Antibody,COVA2-39,,,,RBD,
7BEI,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab,2021-03-03,Antibody,COVOX-150,,,,RBD,
7ND5,EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab,2021-03-03,Antibody,COVOX-150,,,,,
7BEJ,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-158 Fab (crystal form 1),2021-03-03,Antibody,COVOX-158,,,,RBD,
7BEK,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-158 Fab (crystal form 2),2021-03-03,Antibody,COVOX-158,,,,RBD,
7NDC,EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159,2021-03-03,Antibody,COVOX-159,,,,,
7NDD,EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159,2021-03-03,Antibody,COVOX-159,,,,,
7OR9,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and COVOX-278 Fabs,2021-07-07,Antibody,COVOX-222,COVOX-278,,,RBD,
7NX6,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs,2021-04-07,Antibody,COVOX-222,EY6A,,,RBD,
7NX7,Crystal structure of the K417N mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs,2021-04-07,Antibody,COVOX-222,EY6A,,,RBD,Mutant
7NX8,Crystal structure of the K417T mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs,2021-04-07,Antibody,COVOX-222,EY6A,,,RBD,Mutant
7NX9,Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs,2021-04-07,Antibody,COVOX-222,EY6A,,,RBD,Mutant
7NXA,Crystal structure of the receptor binding domain of SARS-CoV-2 B.1.351 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs,2021-04-07,Antibody,COVOX-222,EY6A,,,RBD,Mutant
7NXB,Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs,2021-04-07,Antibody,COVOX-222,EY6A,,,RBD,Mutant
7BEN,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253 and COVOX-75 Fabs,2021-03-03,Antibody,COVOX-253,COVOX-75,,,RBD,
7NDB,EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab,2021-03-03,Antibody,COVOX-253H165L,,,,,
7ND9,EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab,2021-03-03,Antibody,COVOX-253H55L,,,,,
7NDA,EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab,2021-03-03,Antibody,COVOX-253H55L,,,,,
7BEO,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253H55L and COVOX-75 Fabs,2021-03-03,Antibody,COVOX-253H55L,COVOX-75,,,RBD,
7BEM,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 scFv,2021-03-03,Antibody,COVOX-269,,,,RBD,
7NEG,Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab,2021-03-03,Antibody,COVOX-269,,,,,
7NEH,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab,2021-03-03,Antibody,COVOX-269,,,,,
7BEH,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab,2021-03-03,Antibody,COVOX-316,,,,RBD,
7ND7,EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab,2021-03-03,Antibody,COVOX-316,,,,,
7ND8,EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab,2021-03-03,Antibody,COVOX-384,,,,,
7BEP,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-384 and S309 Fabs,2021-03-03,Antibody,COVOX-384,S309,,,RBD,
7ND3,EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab,2021-03-03,Antibody,COVOX-40,,,,,
7ND6,EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab,2021-03-03,Antibody,COVOX-40,,,,,
7ORA,Crystal structure of the T478K mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-45 and COVOX-253 Fabs,2021-07-07,Antibody,COVOX-45,COVOX-253,,,RBD,Mutant
7ORB,Crystal structure of the L452R mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-75 and COVOX-253 Fabs,2021-07-07,Antibody,COVOX-75,COVOX-253,,,RBD,Mutant
7ND4,EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab,2021-03-03,Antibody,COVOX-88,,,,,
7BEL,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-88 and COVOX-45 Fabs,2021-03-03,Antibody,COVOX-88,COVOX-45,,,RBD,
7KZB,Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies,2021-02-03,Antibody,CR3014-C8,CR3022-B6,,,,
6W41,Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022,2020-03-25,Antibody,CR3022,,,,RBD,
6YLA,Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab,2020-04-15,Antibody,CR3022,,,,RBD,
6YM0,Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab (crystal form 1),2020-04-29,Antibody,CR3022,,,,RBD,
6YOR,Structure of the SARS-CoV-2 spike S1 protein in complex with CR3022 Fab,2020-04-29,Antibody,CR3022,,,,,
6ZLR,Soaking competent crystal form of the SARS-CoV-2 Receptor Binding Domain (RBD):CR3022 complex.,2020-12-23,Antibody,CR3022,,,,RBD,
7A5R,Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement),2020-09-16,Antibody,CR3022,,,,"NTD
RBD",
7A5S,Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement),2020-09-16,Antibody,CR3022,,,,"NTD
RBD",
6YZ7,"H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex",2020-06-03,"Antibody
Nanobody/Sybody",CR3022,H11-D4,,,RBD,
6Z2M,"H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex",2020-06-03,"Antibody
Nanobody/Sybody",CR3022,H11-D4,,,RBD,
6ZH9,Ternary complex CR3022 H11-H4 and RBD (SARS-CoV-2),2020-09-02,"Antibody
Nanobody/Sybody",CR3022,H11-H4,,,RBD,
7CM4,Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,2021-01-20,Antibody,CT-P59,,,,RBD,
7KL9,"Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4)",2020-11-11,Other,CTC-445.2,,,,,
7LOP,Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022,2021-03-03,Antibody,CV05-163,CR3022,,,RBD,
6XKQ,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250,2020-10-14,Antibody,CV07-250,,,,RBD,
6XKP,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270,2020-10-14,Antibody,CV07-270,,,,RBD,
7M3I,"Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibody, CV2-75 Fab",2021-05-12,Antibody,CV2-75,,,,RBD,
6XE1,"Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing antibody, CV30 Fab",2020-07-01,Antibody,CV30,,,,RBD,
7LM8,Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients,2021-03-31,Antibody,CV38-142,COVA1-16,,,RBD,
7LQ7,Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16,2021-09-15,Antibody,CV503,COVA1-16,,,RBD,
7LAA,Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041,2021-03-17,Antibody,DH1041,,,,RBD,
7LJR,SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab,2021-03-31,Antibody,DH1043,,,,,
7LD1,Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047,2021-01-27,Antibody,DH1047,,,,RBD,
7LCN,Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1,2021-01-27,Antibody,DH1050.1,,,,NTD,
7LAB,Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052,2021-03-10,Antibody,DH1052,,,,NTD,
7VMU,Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody,2021-11-03,Antibody,E4,,,,RBD,
7C53,Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1,2021-05-19,Other,EK1,,,,HR1,Fusion Peptide
6ZDG,Association of three complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab,2020-07-29,Antibody,EY6A,,,,,
6ZDH,SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab,2020-07-01,Antibody,EY6A,,,,,
6ZER,Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab,2020-06-24,Antibody,EY6A,,,,RBD,
6ZFO,Association of two complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab,2020-07-08,Antibody,EY6A,,,,,
6ZCZ,Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex with EY6A Fab and a nanobody.,2020-06-24,"Antibody
Nanobody/Sybody",EY6A,H11-H4,,,RBD,
7OAY,Nanobody F2 bound to RBD,2021-08-11,Nanobody/Sybody,F2,,,,RBD,
7S3N,SARS-CoV-2 S stem helix peptide bound to Fab22,2021-10-27,Antibody,Fab22,,,,,
7D00,S protein of SARS-CoV-2 in complex bound with FabP5A-1B8,2021-03-10,Antibody,FabP5A-1B8,,,,,
7D03,S protein of SARS-CoV-2 in complex bound with FabP5A-2G7,2021-03-10,Antibody,FabP5A-2G7,,,,,
7D4G,A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2,2021-04-07,Antibody,FC05,,,,,
7CWS,SARS-CoV-2 Spike Proteins Trimer in Complex with FC05 and H014 Fabs Cocktail,2020-12-16,Antibody,FC05,H014,,,,
7DX4,The structure of FC08 Fab-hA.CE2-RBD complex,2021-04-21,Antibody,FC08,,,,RBD,
7CYV,"Crystal structure of FD20, a neutralizing single-chain variable fragment (scFv) in complex with SARS-CoV-2 Spike receptor-binding domain (RBD)",2021-09-15,Antibody,FD20,,,,RBD,
7N64,SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction),2021-08-04,Antibody,G32R7,,,,,
7D6I,A neutralizing MAb targeting receptor-binding-domain of SARS-CoV-2,2021-10-13,Antibody,GH12,,,,RBD,
7CAC,SARS-CoV-2 S trimer with one RBD in the open state and complexed with one H014 Fab.,2021-02-24,Antibody,H014,,,,,
7CAH,The interface of H014 Fab binds to SARS-CoV-2 S,2020-08-12,Antibody,H014,,,,,
7CAI,SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab,2020-09-23,Antibody,H014,,,,,
7CAK,SARS-CoV-2 S trimer with three RBD in the open state and complexed with three H014 Fab,2020-09-23,Antibody,H014,,,,,
7E5R,SARS-CoV-2 S trimer with three-antibody cocktail complex,2021-10-13,Antibody,H014,P17,FC05,,,
7E5S,SARS-CoV-2 S trimer with four-antibody cocktail complex,2021-11-17,Antibody,H014,P17,FC05,HB27,,
6YZ5,H11-D4 complex with SARS-CoV-2 RBD,2020-06-03,Nanobody/Sybody,H11-D4,,,,RBD,
6Z43,Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex,2020-06-03,Nanobody/Sybody,H11-D4,,,,,
6ZBP,H11-H4 complex with SARS-CoV-2,2020-07-29,Nanobody/Sybody,H11-H4,,,,,
6ZHD,H11-H4 bound to Spike,2020-07-29,Nanobody/Sybody,H11-H4,,,,,
7OAP,Nanobody H3 AND C1 bound to RBD,2021-08-11,Nanobody/Sybody,H3,C1,,,RBD,
7OAQ,Nanobody H3 AND C1 bound to RBD with Kent mutation,2021-08-11,Nanobody/Sybody,H3,C1,,,RBD,Mutant
7L58,Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4,2021-04-14,Antibody,H4,,,,,
7CYH,Binding interface of SARS-CoV-2 RBD and its neutralizing antibody HB27,2021-06-09,Antibody,HB27,,,,RBD,
7CYP,Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27,2021-06-09,Antibody,HB27,,,,,
7CWT,SARS-CoV-2 Spike protein in complex with hb27 and fc05 Fab cocktail,2021-06-23,Antibody,HB27,FC05,,,,
7BNV,Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-300,2021-11-17,Antibody,ION-300,,,,RBD,
7NP1,Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360,2021-11-17,Antibody,ION-360,,,,RBD,
7FG3,"Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map",2021-09-29,Nanobody/Sybody,K-874 VHH,,,,,
7FG2,"Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map",2021-09-29,Nanobody/Sybody,K-874A VHH,,,,,
7JZL,SARS-CoV-2 spike in complex with LCB1 (2RBDs open),2020-09-23,Other,LCB1,,,,,Protein Inhibitor
7JZU,SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1),2020-09-23,Other,LCB1,,,,,Protein Inhibitor
7JZM,SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3),2020-09-23,Other,LCB3,,,,,Protein Inhibitor
7JZN,SARS-CoV-2 spike in complex with LCB3 (2RBDs open),2020-09-23,Other,LCB3,,,,,Protein Inhibitor
7RXD,CryoEM structure of RBD domain of COVID-19 in complex with Legobody,2021-10-06,Other,Legobody,,,,RBD,Nanobody attached to two scaffolds.
7MMO,LY-CoV1404 neutralizing antibody against SARS-CoV-2,2021-05-12,Antibody,LY-CoV1404,,,,,
7KMI,LY-CoV481 neutralizing antibody against SARS-CoV-2,2021-01-27,Antibody,LY-CoV481,,,,,
7KMH,LY-CoV488 neutralizing antibody against SARS-CoV-2,2021-01-27,Antibody,LY-CoV488,,,,,
7KMG,LY-CoV555 neutralizing antibody against SARS-CoV-2,2021-01-27,Antibody,LY-CoV555,,,,,
7L3N,SARS-CoV 2 Spike Protein bound to LY-CoV555,2021-02-03,Antibody,LY-CoV555,,,,RBD,
7KKL,SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6,2020-11-11,Antibody,mNb6,,,,,
7C8W,Structure of sybody MR17 in complex with the SARS-CoV-2 S receptor-binding domain (RBD),2020-06-24,Nanobody/Sybody,MR17,,,,RBD,
7CAN,Structure of sybody MR17-K99Y in complex with the SARS-CoV-2 S Receptor-binding domain (RBD),2020-06-24,Nanobody/Sybody,MR17-K99Y,,,,RBD,
7D30,Structure of sybody MR17-SR31 fusion in complex with the SARS-CoV-2 S Receptor Binding domain (RBD),2021-02-17,Nanobody/Sybody,MR17-SR31,,,,RBD,
7DJZ,Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab,2021-06-09,Antibody,MW01,,,,RBD,
7DK0,Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab,2021-06-09,Antibody,MW05,,,,RBD,
7DPM,Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab,2021-02-17,Antibody,MW06,,,,RBD,
7S0E,Structure of the SARS-CoV-2 S1 subunit in complex with antibody N-612-004,2021-10-06,Antibody,N-612-004,,,,,
7S0D,Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014,2021-10-06,Antibody,N-612-014,,,,,
7S0C,Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017,2021-10-06,Antibody,N-612-017,,,,,
7S0B,Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody N-612-056,2021-10-06,Antibody,N-612-056,,,,RBD,
7E7X,SARS-CoV-2 Spike Protein N terminal domain in Complex with N11 Fab,2021-06-09,Antibody,N11,,,,NTD,
7VNB,Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113,2021-11-24,Nanobody/Sybody,n3113,,,,RBD,Not referred to as nanboody but seems like human-derived nanobody.
7VNC,"Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)",2021-11-24,Nanobody/Sybody,n3113,,,,RBD,Not referred to as nanboody but seems like human-derived nanobody.
7VND,"Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UUD-state, state 2)",2021-11-24,Nanobody/Sybody,n3113,,,,RBD,Not referred to as nanboody but seems like human-derived nanobody.
7VNE,Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113.1 (UUU-state),2021-11-24,Nanobody/Sybody,n3113,,,,RBD,Not referred to as nanboody but seems like human-derived nanobody.
7E8F,SARS-CoV-2 NTD in complex with N9 Fab,2021-06-09,Antibody,N9,,,,NTD,
7KM5,Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1,2021-08-04,Nanobody/Sybody,Nanosota-1,,,,RBD,
7MY3,CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike,2021-06-16,Nanobody/Sybody,Nb12,,,,,
7N9T,CryoEM structure of SARS-CoV-2 Spike in complex with Nb17,2021-08-11,Nanobody/Sybody,Nb17,,,,,
7ME7,CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb17 and Nb105,2021-08-11,Nanobody/Sybody,Nb17,Nb105,,,RBD,
7JVB,Crystal structure of the SARS-CoV-2 spike receptor-binding domain (RBD) with nanobody Nb20,2020-12-02,Nanobody/Sybody,Nb20,,,,RBD,
7N9A,Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS RBD with NB21,2021-08-04,Nanobody/Sybody,Nb21,,,,RBD,
7N9B,Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB21,2021-08-04,Nanobody/Sybody,Nb21,,,,,
7MDW,CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb105,2021-08-11,Nanobody/Sybody,Nb21,Nb105,,,RBD,
7MEJ,CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb36,2021-08-11,Nanobody/Sybody,Nb21,Nb36,,,RBD,
7MY2,CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike,2021-06-16,Nanobody/Sybody,Nb30,,,,,
7N9E,Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB34,2021-08-04,Nanobody/Sybody,Nb34,,,,,
7KKK,SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6,2020-11-11,Antibody,Nb6,,,,,
7N9C,Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB95,2021-08-04,Nanobody/Sybody,Nb95,,,,,
7E3O,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody nCoV617,2021-09-15,Antibody,nCoV617,,,,RBD,
7NKT,RBD domain of SARS-CoV2 in complex with neutralizing nanobody NM1226,2021-05-12,Nanobody/Sybody,NM1226,,,,RBD,
7B27,RBD domain SARS-CoV2 in complex with neutralizing nanobody NM1230,2021-05-12,Nanobody/Sybody,NM1230,,,,RBD,
7E5O,Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193,2021-09-08,Antibody,NT-193,,,,RBD,
7NTC,Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab,2021-04-28,Antibody,P008_056,,,,,
7CWL,SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state,2021-01-27,Antibody,P17,,,,,
7CWM,Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state,2020-12-16,Antibody,P17,,,,,
7CWO,SARS-CoV-2 spike protein RBD and P17 fab complex,2020-12-16,Antibody,P17,,,,RBD,
7CWU,SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail,2020-12-16,Antibody,P17,FC05,,,,
7CWN,P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein,2020-12-16,Antibody,P17,H014,,,,
7CHS,Crystal structure of SARS-CoV-2 antibody P22A-1D1 with RBD,2021-05-19,Antibody,P22A-1D1,,,,RBD,
7CZP,S protein of SARS-CoV-2 in complex bound with P2B-1A1,2021-03-10,Antibody,P2B-1A1,,,,,
7CZQ,S protein of SARS-CoV-2 in complex bound with P2B-1A10,2021-03-10,Antibody,P2B-1A10,,,,,
7BWJ,crystal structure of SARS-CoV-2 antibody with RBD,2020-06-03,Antibody,P2B-2F6,,,,RBD,
7CDJ,Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD,2020-11-18,Antibody,P2C-1A3,,,,RBD,
7CDI,Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD,2020-11-18,Antibody,P2C-1F11,,,,RBD,
7E8M,Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD,2021-05-26,Antibody,P2C-1F11,,,,RBD,Mutated RBD
7CJF,Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody Fab,2020-11-11,Antibody,P4A1,,,,RBD,
7CZU,S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B,2021-03-10,Antibody,P5A-1B6_2B,,,,,
7CZV,S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B,2021-03-10,Antibody,P5A-1B6_3B,,,,,
7CZR,S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B,2021-03-10,Antibody,P5A-1B8_2B,,,,,
7CZS,S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B,2021-03-10,Antibody,P5A-1B8_3B,,,,,
7CZX,S protein of SARS-CoV-2 in complex bound with P5A-1B9,2021-03-10,Antibody,P5A-1B9,,,,,
7CHO,Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD,2021-05-19,Antibody,P5A-1D2,,,,RBD,
7CZY,S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B,2021-03-10,Antibody,P5A-2F11_2B,,,,,
7CZZ,S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B,2021-03-10,Antibody,P5A-2F11_3B,,,,,
7CZW,S protein of SARS-CoV-2 in complex bound with P5A-2G7,2021-03-10,Antibody,P5A-2G7,,,,,
7CZT,S protein of SARS-CoV-2 in complex bound with P5A-2G9,2021-03-10,Antibody,P5A-2G9,,,,,
7D0C,S protein of SARS-CoV-2 in complex bound with P5A-3A1,2021-03-10,Antibody,P5A-3A1,,,,,
7D0B,S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B,2021-03-10,Antibody,P5A-3C12_1B,,,,,
7D0D,S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B,2021-03-10,Antibody,P5A-3C12_2B,,,,,
7CHP,Crystal structure of SARS-CoV-2 antibody P5A-3C8 with RBD,2021-05-19,Antibody,P5A-3C8,,,,RBD,
7P40,P5C3 is a potent fab neutralizer,2021-10-13,Antibody,P5C3,,,,RBD,
7PHG,MaP OF P5C3RBD Interface,2021-10-13,Antibody,P5C3,,,,RBD,
7MZL,SARS-CoV-2 receptor binding domain bound to Fab PDI 210,2021-10-06,Antibody,PDI 210,,,,RBD,
7MZM,SARS-CoV-2 receptor binding domain bound to Fab PDI 215,2021-10-06,Antibody,PDI 215,,,,RBD,
7RR0,SARS-CoV-2 receptor binding domain bound to Fab PDI 222,2021-10-06,Antibody,PDI 222,,,,RBD,
7MZN,SARS-CoV-2 receptor binding domain bound to Fab PDI 231,2021-10-06,Antibody,PDI 231,,,,RBD,
7MZF,SARS-CoV-2 receptor binding domain bound to Fab PDI 37,2021-10-06,Antibody,PDI 37,,,,RBD,
7MZG,SARS-CoV-2 receptor binding domain bound to Fab PDI 42,2021-10-06,Antibody,PDI 42,,,,RBD,
7DEO,Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv,2021-03-31,Antibody,PR1077,,,,RBD,
7DEU,Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv,2021-03-31,Antibody,PR953,,,,RBD,
7DET,Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv,2021-03-31,Antibody,PR961,,,,RBD,
7EJ4,Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25,2021-06-23,Antibody,RBD-chAb-25,,,,,
7EJ5,Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45,2021-06-23,Antibody,RBD-chAb-45,,,,,
7EH5,"Cryo-EM structure of SARS-CoV-2 S-D614G variant in complex with neutralizing antibodies, RBD-chAb15 and RBD-chAb45",2021-09-01,Antibody,RBD-chAb15,RBD-chAb45,,,,
7OLZ,Crystal structure of the SARS-CoV-2 RBD with neutralizing-VHHs Re5D06 and Re9F06,2021-08-11,Nanobody/Sybody,Re5D06,Re9F06,,,RBD,
6XDG,Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies,2020-06-24,Antibody,REGN10933,REGN10987,,,RBD,
7M42,Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989,2021-07-28,Antibody,REGN10989,REGN10985,,,RBD,
7KN3,Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-B8 Fab,2021-09-22,Antibody,S-B8,,,,RBD,
7KN4,Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-E6 Fab,2021-09-22,Antibody,S-E6,,,,RBD,
7JVA,SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains),2020-10-14,Antibody,S2A4,,,,,
7JVC,SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment,2020-10-14,Antibody,S2A4,,,,,
7R7N,SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106),2021-07-21,Antibody,S2D106,,,,,
7K45,SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains),2020-10-07,Antibody,S2E12,,,,,
7K4N,SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment,2020-10-07,Antibody,S2E12,,,,,
7R6X,"SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab",2021-07-21,Antibody,S2E12,S309,S304,,RBD,
7JV2,SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains),2020-10-14,Antibody,S2H13,,,,,
7JV4,SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open),2020-10-14,Antibody,S2H13,,,,,
7JV6,SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation),2020-10-14,Antibody,S2H13,,,,,
7N8I,SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20),2021-07-14,Antibody,S2L20,,,,,Mutant
7SOA,SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement,2021-11-17,Antibody,S2L20,,,,NTD,Mutant
7SOD,SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement,2021-11-17,Antibody,S2L20,,,,NTD,Mutant
7LXX,SARS-CoV-2 S/S2M11/S2L28 Local Refinement,2021-04-14,Antibody,S2L28,,,,,
7K43,SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment,2020-10-07,Antibody,S2M11,,,,,
7N8H,SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement,2021-07-14,Antibody,S2M11,S2L20,,,,Mutant
7SO9,SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement,2021-11-17,Antibody,S2M11,S2L20,,,,Mutant
7LXZ,SARS-CoV-2 S/S2M11/S2L28 Global Refinement,2021-04-14,Antibody,S2M11,S2L28,,,,
7LY2,SARS-CoV-2 S/S2M11/S2M28 Global Refinement,2021-04-14,Antibody,S2M11,S2M28,,,,
7LXY,SARS-CoV-2 S/S2M11/S2X333 Global Refinement,2021-04-14,Antibody,S2M11,S2X333,,,,
7LY0,SARS-CoV-2 S/S2M11/S2M28 Local Refinement,2021-04-14,Antibody,S2M28,,,,,
7LY3,Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab,2021-04-14,Antibody,S2M28,,,,NTD,
7RNJ,S2P6 Fab fragment bound to the SARS-CoV/SARS-CoV-2 spike stem helix peptide,2021-08-11,Antibody,S2P6,,,,,
7RA8,SARS-CoV-2 S glycoprotein in complex with S2X259 Fab,2021-08-04,Antibody,S2X259,,,,,
7RAL,SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains),2021-08-04,Antibody,S2X259,,,,,
7M7W,Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape,2021-05-05,Antibody,S2X259,S2H97,,,RBD,
7SOE,SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement,2021-11-17,Antibody,S2X303,,,,,Mutant
7SOF,SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement,2021-11-17,Antibody,S2X303,,,,NTD,Mutant
7LXW,SARS-CoV-2 S/S2M11/S2X333 Local Refinement,2021-04-14,Antibody,S2X333,,,,,
7R6W,SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab,2021-07-21,Antibody,S2X35,S309,,,RBD,
7JW0,SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment,2020-10-14,Antibody,S304,,,,,
6WPS,Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment,2020-05-27,Antibody,S309,,,,,
6WPT,Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state),2020-05-27,Antibody,S309,,,,,
7SOC,SARS-CoV-2 S RBD B.1.617.1 kappa variant S309 Local Refinement,2021-11-17,Antibody,S309,,,,RBD,Mutant
7JX3,Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology,2020-10-14,Antibody,S309,S2H14,S304,,,
7SOB,SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement,2021-11-17,Antibody,S309,S2L20,,,,Mutant
7L0N,Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity,2021-02-17,Antibody,S309,S304,,,RBD,
7MKL,SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation),2021-05-12,Antibody,SARS2-38,,,,,
7MKM,SARS-CoV-2 Spike RBD in complex with neutralizing Fab SARS2-38 (local refinement),2021-05-12,Antibody,SARS2-38,,,,RBD,
7P77,SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation,2021-08-04,Nanobody/Sybody,Sb#15,Sb#68,,,RBD,
7P78,SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation,2021-08-04,Nanobody/Sybody,Sb#15,Sb#68,,,RBD,
7P79,SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.,2021-08-04,Nanobody/Sybody,Sb#15,Sb#68,,,RBD,
7P7A,SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation,2021-08-04,Nanobody/Sybody,Sb#68,,,,RBD,
7P7B,SARS-CoV-2 spike protein in complex with sybody#68 in a 1up/2down conformation,2021-08-04,Nanobody/Sybody,Sb#68,,,,RBD,
7MFU,Crystal structure of synthetic nanobody (Sb14+Sb68) complexes with SARS-CoV-2 receptor binding domain,2021-06-02,Nanobody/Sybody,Sb14,Sb68,,,RBD,
7KGK,Crystal structure of synthetic nanobody (Sb16) complexes with SARS-CoV-2 receptor binding domain,2021-02-03,Nanobody/Sybody,Sb16,,,,,
7A25,Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23),2020-11-25,Nanobody/Sybody,Sb23,,,,,
7A29,Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation,2020-10-21,Nanobody/Sybody,Sb23,,,,,
7KGJ,Crystal structure of synthetic nanobody (Sb45) complexes with SARS-CoV-2 receptor binding domain,2021-02-03,Nanobody/Sybody,Sb45,,,,RBD,
7N0G,"CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45)",2021-06-02,Nanobody/Sybody,Sb45,,,,,
7N0H,"CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45)",2021-06-02,Nanobody/Sybody,Sb45,,,,,
7KLW,Crystal structure of synthetic nanobody (Sb45+Sb68) complexes with SARS-CoV-2 receptor binding domain,2021-02-03,Nanobody/Sybody,Sb45,Sb68,,,RBD,
7D2Z,Structure of sybody SR31 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD),2021-02-17,Nanobody/Sybody,SR31,,,,RBD,
7C8V,Structure of sybody SR4 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD),2020-06-24,Nanobody/Sybody,SR4,,,,RBD,
7B3O,Crystal structure of the SARS-CoV-2 RBD in complex with STE90-C11 Fab,2020-12-16,Antibody,STE90-C11,,,,RBD,
6ZXN,Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1),2020-09-23,Nanobody/Sybody,Ty1,,,,,
7MJH,Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8,2021-05-12,Antibody,VH ab8,,,,,Mutant
7MJI,Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8 (focused refinement of RBD and VH ab8),2021-05-12,Antibody,VH ab8,,,,,Mutant
7JWB,SARS CoV2 Spike ectodomain with engineered trimerized VH binder,2020-10-07,Nanobody/Sybody,VH3 B01,,,,,Not referred to as nanboody but seems like human-derived nanobody.
7B14,Nanobody E bound to Spike-RBD in a localized reconstruction,2021-04-28,Nanobody/Sybody,VHH E,,,,,
7KSG,SARS-CoV-2 spike in complex with nanobodies E,2021-01-20,Nanobody/Sybody,VHH E,,,,,
7KN5,Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U,2021-01-20,Nanobody/Sybody,VHH E,VHH U,,,RBD,
7B17,SARS-CoV-spike RBD bound to two neutralising nanobodies.,2021-02-10,Nanobody/Sybody,VHH VE,,,,RBD,
7B18,SARS-CoV-spike bound to two neutralising nanobodies,2021-04-28,Nanobody/Sybody,VHH VE,,,,,
7MZH,SARS-CoV-2 receptor binding domain bound to Fab WCSL 119,2021-10-06,Antibody,WCSL 119,,,,RBD,
7MZI,SARS-CoV-2 receptor binding domain bound to Fab WCSL 129,2021-10-06,Antibody,WCSL 129,,,,RBD,
7MZJ,SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 93,2021-10-06,Antibody,WCSL 129,PDI 93,,,RBD,
7MZK,SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96,2021-10-06,Antibody,WCSL 129,PDI 96,,,RBD,
7LX5,The SARS-CoV-2 spike protein receptor binding domain bound to neutralizing nanobodies WNb 2 and WNb 10,2021-05-05,Nanobody/Sybody,WNb 2,WNb 10,,,RBD,
7LDJ,SARS-CoV-2 receptor binding domain in complex with WNb-2,2021-05-05,Nanobody/Sybody,WNb-2,,,,RBD,
7N4I,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057.,2021-10-06,Antibody,WRAIR-2057,,,,RBD,
7N4L,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2125.,2021-11-10,Antibody,WRAIR-2125,,,,RBD,
7N4M,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151.,2021-11-10,Antibody,WRAIR-2151,,,,RBD,
7N4J,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173.,2021-10-06,Antibody,WRAIR-2173,,,,RBD,
7V26,XG005-bound SARS-CoV-2 S,2021-10-20,Antibody,XG005,,,,RBD,
7V2A,SARS-CoV-2 Spike trimer in complex with XG014 Fab,2021-10-20,Antibody,XG014,,,,RBD,
